Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7339370

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-378,872,000 JPY
-325,578,000 JPY
Non-operating income
Non-operating income
19,187,000 JPY
3,341,000 JPY
Non-operating expenses
Non-operating expenses
3,607,000 JPY
855,000 JPY
Ordinary profit (loss)
-363,292,000 JPY
-323,092,000 JPY
Extraordinary income
Extraordinary income
JPY
136,000 JPY
Profit (loss) before income taxes
-363,292,000 JPY
-322,955,000 JPY
Income taxes - current
940,000 JPY
736,000 JPY
Profit (loss)
-364,233,000 JPY
-323,691,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.